Get started
Author

Zhiqiang Zhan

Observed name: Zhan, Zhiqiang
ORCID: 0000-0003-0232-8328
Observed ORCID: 0000-0003-0232-8328
OpenAlex ID: A5129718541
Carnosic Acid Induces Antiproliferation and Anti-Metastatic Property of Esophageal Cancer Cells via MAPK Signaling Pathways
2021 · Sicong Jiang, Yinda Qiu, et al. · Journal of Oncology · 13
PDF
Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis
2026 · Ziqi Zhu, Meng Zhang, et al. · BMC Gastroenterology · 1
Chinese expert consensus on radiotherapy combined with immunotherapy for unresectable lung cancer (2026 Edition)
2026 · Linlin Wang, Ying Liu, et al. · Cancer Letters
Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis
2026 · Zhu, Ziqi, Zhang, Meng, et al. · Figshare
Additional file 4 of Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis
2026 · Zhu, Ziqi, Zhang, Meng, et al. · Figshare
Additional file 3 of Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis
2026 · Zhu, Ziqi, Zhang, Meng, et al. · Figshare
Additional file 2 of Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis
2026 · Zhu, Ziqi, Zhang, Meng, et al. · Figshare
Additional file 5 of Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis
2026 · Zhu, Ziqi, Zhang, Meng, et al. · Figshare
Additional file 1 of Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis
2026 · Zhu, Ziqi, Zhang, Meng, et al. · Figshare
Exploring the role of lipid metabolism genes in gastric cancer prognosis and tumor immune microenvironment
2025 · Yanan Xiao, Qin Yu, et al. · Journal of International Medical Research
WITHDRAWN: Developing a Risk Model of Lipid Metabolism-associated Genes: Implications for Clinical Prognosis and Tumor Immune Microenvironment in Gastric Cancer
2024 · Yanan Xiao, Qin Yu, et al. · Research Square
PDF
RETRACTED: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer
2022 · Zhiqiang Zhan, Jiaqi Mei, et al. · Frontiers in Oncology
PDF
Works count: 12
Citation count: 14
H-index: 1
I10-index: 1
Year
Topic
Type